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A number of recent papers have described the properties of molecules on the 
surface of T cells that appear to be the receptors for antigen (Ag) ~  plus a product 
of the major histocompatibility complex (MHC) on these cells  (1-6).  In nearly 
every case these molecules were isolated using monoclonal antibodies prepared 
by  inmmnizing mice  or  rats  with  cloned  T  cell  lines  or  hybridomas.  These 
ntonoclonal antibodies were found to be clone-specific,  in that they reacted only 
with a glycoprotein on the surface of the T  cells used for immunization and not 
with proteins on closely related T  cells known to have different fine specificities 
for Ag/MHC. The clone specificity of these antibodies is, in fact, an important 
component of the  evidence that  they are  indeed reacting with  the  Ag/MHC 
receptors on  their target T  cell  clones and  not  some  other surface molecule 
involved in T  cell Ag recognition and activation. 
While these antibodies have contributed tremendously to our understanding 
of T  cell receptors, they have not been of much use in dissecting the events in 
the life history of the T  cell  in vivo, since they react with an undetectably low 
percentage of normal T  cells.  For these purposes an antibody directed against a 
nonidiotypic portion of the T  cell receptor is needed. McIntyre and Allison (7) 
have described  such  a  reagent in  the shape  of a  rabbit  antiserum against the 
receptor fi'om a C57BL/6 T  cell leukemia. The antiserum precipitates receptors 
from normal  mouse thymocytes and peripheral  T  cells,  and has been  used to 
analyze constant and variable peptides in the glycoprotein (7).  Recently, Bigler 
et al. have described the production of a monoclonal antibody to a human T  cell 
leukemia that seems to cross-react with ~2%  of human peripheral  T  cells  (8). 
Since analysis with monoclonal antibodies is considerably easier than with whole 
antisera, we set out to make a similar reagent against mouse T  cell receptors. 
This paper describes the production and some of the properties of such  an 
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potyacrylamide gel eleclrophoresis; SDS, sodium dodedyl sulphate; SN, supernatant; TGAL, poly L 
(Tyr,Glu)-poly-D,l.-Ala-poly-L-Lys. 
432  J. ExP. MED. © The Rockefeller University Press  • 0022-1007/84/08/0452/20  $1.00 
Volume 160  August 1984  452-471 HASKINS ET  AL.  453 
antibody. The monoclonal antibody, KJ 16-133, was produced by immunizing a 
rat with the Ag/MHC receptor from a T  cell hybridoma DO-11.10, specific for 
chicken  ovalbumin  and  I-A  a  (OVA/I-A a,  9).  The  antibody  inhibits  Ag/MHC 
recognition by DO-1 I. 10 and several other T  cell hybridomas to which it binds, 
but stimulates others also bearing the determinant it recognizes and has no effect 
on Ag/MHC recognition by T  cell hybrids to which it does not bind.  KJ16-133 
precipitates  the  85-kd  heterodimeric,  Ag/MHC  receptor from  DO-11.10  and 
several other T  cell hybridomas, including 3DT-52.5, a T  cell hybridoma specific 
for  D a  (10).  The  monoclonal antibody  precipitates  similar  molecules from pe- 
ripheral T  cells of most but not all strains of mice. Fluorescence studies showed 
that KJ16-133 detected the receptor on ~20% of peripheral T  cells. Thus, this 
antibody  detects an  allotypic determinant  present  on  some  but  not  all  T  cell 
receptors. 
Materials and Methods 
Production and Characterization of T Cell Hybridomas Bearing Ag/MHC Receptors.  T cell 
hybridomas were produced as previously described by fusing Ag-primed, murine T  cell 
blasts to the AKR thymoma BW5147 with polyethylene glycol (9-11). The Ags involved 
included chicken ovalbumin (cOVA, Sigma Chemical Co., St.  Louis, MO), poly L (Tyr, 
Glu)-poly-D,L-Ala-poly-L-Lys  (TGAL,  Miles  Laboratories,  Inc.,  Elkhart,  IN),  human 
gamma globulin  (HgG,  Sigma  Chemical  Co.) and  Keyhole limpet hemocyanin (KLH, 
Calbiochem-Behring Corp.,  American  Hoeschst Corp.,  San  Diego, CA).  Hybrids were 
selected with hypoxanthine, aminopterin, and thymidine (HAT; Sigma Chemical Co.) and 
screened for the presence of receptors for Ag/MHC by their ability to secrete interleukin 
2 (I L-2) in response to Ag and Ag-presenting cells of the appropriate H-2 type (11). These 
Ag-presenting  cells  were  usually  Ia  ÷  B  cell  lymphomas  or  hybridomas,  but  in  some 
experiments fresh spleen  cells  were  used  (12).  After the T  cell hybridomas had been 
incubated for 24 h with Ag and Ag-presenting cells, supernatants (SNs) were assayed for 
their IL-2 content by titrating their ability to support the growth of the IL-2-dependent 
T cell line, HT-2, as previously described (11). Serial twofold dilutions of the SNs allowed 
us to measure how much  IL-2 was in each one, one unit of IL-2 being defined as the 
minimum amount required to keep ~90% of 4,000 HT-2 cells alive in 0.1  ml of culture 
medium for 24 h. Table II lists the T  cell hybridomas used in this paper and also their 
sources and reactivities. 
In  some  cases  DO-11.10/$4.4,  a  subclone of DO-11.10  selected for high  receptor 
expression by immunofluorescent staining with the clone-specific anti-receptor antibody 
directed at  DO-11.10, KJ1-26 (2),  sorted and recloned, was used instead of DO-11.10. 
DO-11.10/$4.4 bears about twice as much receptor/cell as DO-1 I. 10. The two lines were 
used interchangeably for the experiments described in this paper. 
Animals.  BALB/cBy and  SJL/J  were obtained  from The Jackson  Laboratory, Bar 
Harbor, ME or were bred in our colony from breeding triplets obtained from this source. 
SJA/20 mice were bred in our colony from breeding triplets obtained from Dr.  L.  A. 
Herzenberg, Stanford University, Palo Alto, CA. 
Outbred Sprague Dawley rats were purchased from local sources. 
Preparation of the Ag/MHC Receptor  from DO-11.10.  The Ag/MHC receptor from DO- 
11.10 was isolated from N P-40 lysates of the cells (surface labeled with 125I [13, 14]) using 
a clone-specific antibody, KJ1-26.1. The properties of this antibody have been described 
elsewhere; it reacts with an idiotypic determinant on the Ag/MHC receptors of DO-11.10 
(2). The antibody was used in two ways to isolate receptors. In the first method, NP-40 
|ysates of DO-I 1.10 were incubated with  K  J1-26 and  the antigen-antibody complexes 
were precipitated with Staphylococcus aureus (15). After thorough washing this preparation 
was  used  to  immunize rats.  In  the  second method,  KJ1-26  was  coupled to Sepharose 
beads,  which  were  then  incubated  with  NP-40  lysates  of DO-11.10.  After  thorough 454  ANTIBODY TO  A  T  CELL  RECEPTOR  ALLOTYPE 
washing, the receptor was removed from columns of these beads using 0.05 M diethyla- 
mine, pH  11.5. The eluate was immediately neutralized with Tris and used as described 
below. 
Production of Monoclonal Antibody to T Cell Receptors.  Rats vcere immunized subcuta- 
neously with tbe complex of DO-11.10 Ag/MHC receptor, KJ1-26 and S. aureus every 2 
or  3  wk.  The  first  immunization  was  given  in  complete  Freund's  adjuvant,  and  later 
immunizations  were  in  incomplete  Freund's  adjuvant.  Each immunization  consisted  of 
between  10  ~ and  109 cell equivalents of DO-11.10 receptor.  After about five immuniza- 
tions the  rats  began  to make antibodies  against  the  receptor on  DO-11.10  and  similar 
material  on peripheral  BALB/c T  cells, as judged  by immunoprecipitation.  After eight 
immunizations one  rat  was rested  for a  month,  followed by a  final  immunization  with 
receptor from ~ 109 DO-11.10 isolated using KJ 1-26 beads and diethylamine (see above). 
The  rat  was immunized  subcutaneously,  intraperitoneally,  and  intravenously.  3  d  later 
spleen and draining lymph node cells from this animal were treated with an anti-T cell 
antibody and guinea pig complement (16), and  fused to the nonsecreting plasmacytoma 
P3-X63 Ag8.653/3.  Hybrids were selected with HAT, and when grown up, their super- 
natants were assayed for anti-DO-11.10 receptor antibodies by ELISA (see below). 
ELISA for Anti-receptor Antibodies.  The  receptor  from  DO-11.I0  was  isolated  from 
anti-receptor coupled beads as described above.  An amount equivalent to 3  x  106 DO- 
ll.10  cells  was added  to  half the  wells  of a  nitrocellulose  ELISA plate  (STHA09610, 
Millipore Corp., Bedford, MA) and incubated in the well for 1 h to allow binding of the 
protein  to the  nitrocellulose  filter.  Monitoring with  radiolabeled  receptor  showed that 
nearly all the protein bound irreversibly to the filter. Control wells were left empty. After 
1 h  100  tsl  of fetal  bovine  serum  was added  to all  wells  to saturate  the  nitrocellulose 
binding sites.  1 h later the plates were thoroughly washed with balanced salt solution and 
blotted  dry.  80  ul  of SNs  to be  tested  for anti-receptor  activity were  then  added  to a 
receptor-bound well and, as a  control, to a  well  to which no receptor bad been added. 
The plates were incubated for 1 h at room temperature and then thoroughly washed by 
suction.  100 tal of a  1:250 dilution of atkaline-phosphatase-coupled rabbit antibody to rat 
immunoglobulins (Sigma Chemical Co.) was then added for a further hour. After, again, 
thorough washing, an alkaline phosphatase substrate, p-nitrophenyl phosphate, was added 
in the appropriate buffer (17), and the plates incubated at 37°C for 20 min. Supernatants 
were  then  transferred  to  flat-bottomed  plastic  microtiter  plates,  and  the  amount  of 
substrate converted estimated using an ELISA reader (Bio-Tek Instruments, Burlington, 
VT). Controls included assay of receptor containing wells and empty wells with culture 
medium instead of hybridoma supernatant or with KJ 1-26, the mouse clonotypic antibody 
to DO-I 1.10 receptor.  In the latter case alkaline phosphatase-coupled rabbit antibodies 
to mouse immunoglobulins were used instead of antibodies to rat immunoglobulins (Sigma 
Chemical Co.). 
Preparation  of T Cells.  T  cells  were prepared  from the  spleens and  lymph nodes of 
normal  animals  by  treating  the  cell  suspensions  with  Gey's solution  (18)  followed  by 
incubating them on, and eluting them from, nylon fiber columns (19). 
Surface Labeling and Lysis of Hybridoma or Normal T Cells.  Cells were labeled with 125I 
using iodogen and standard techniques (13,  14). After thorough washing they were lysed 
with  0.5%  NP-40  in  phosphate-buffered  saline  and  insoluble  material  was removed by 
centrifugation. 
lmmunoprecipitations.  Immunoprecipitations were done in several ways. Several of the 
mouse monoclonal antibodies  used  in  this  paper  (KJ1-26,  KJ12-98) have been  purified 
and coupled  to Sepharose  beads.  These  were used  to isolate  material  binding to these 
antibodies.  The rat antibodies  used in these studies, T24/40.7  (rat anti-mouse Thy-l.2, 
the  kind  gift of Dr.  Ian Trowbridge,  Salk  Institute,  La Jolla,  CA) and  KJ16-133, were 
incubated with rabbit or goat anti-rat immunoglobulin (Rockland, Inc., Gilbertsville, PA) 
coupled  to Sepharose  beads.  These  beads  were  then  thoroughly washed  before  use  in 
isolating material from lysates. Bound receptor was eluted from beads by boiling in sample 
buffer (20) or with dietbylamine followed by neutralization (see above). 
Gel Electrophoresis of Immunoprecipitates.  Samples  were  run  under  nonreducing  or HASKINS  ET  AL.  455 
reducing conditions by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS- 
PAGE) as described by Laemmli (20).  a- and B-chains of the reduced T  cell receptors 
were separated as previously described by nonequilibrium pH gradient electrophoresis 
(NEPHGE) (21, 22). 
Immunofluorescence  Staining.  Cells  were  washed  and  stained  in  phosphate-buffered 
saline containing 1% FBS and 0.2% sodium azide (PBS:FCS:AZ). The cells were incubated 
with an  appropriate dilution of the primary antibody (KJ16-133.18) at  4°C  or 37°C 
for 20  min, at a  cell concentration of 107/ml.  Control cells  were incubated in diluent 
without the primary antibody. The cells were then washed twice and incubated for 15 
rain at 4°C with an appropriate dilution of an affinity-purified, fluorescein-conjugated, 
mouse anti-rat kappa chain monoclonal antibody, MAR-18.5 (FL-MAR-18, the kind gift 
of Drs. Larry Arnold, University N. Carolina, Chapel Hill, NC and Lewis Lanier, Becton 
Dickinson, Mountain View,  CA).  The cells were then washed twice and resuspended at 
106 cells/ml. Staining with KJ 1-26 was done with directly fluoresceinated F(ab')2 KJ1-26 
antibody (FL-KJ1). In this case cells were incubated at 107/ml as above, but no secondary 
antibody was used. 
In  experiments in  which  the  competitive binding of different antibodies was  to be 
examined cells were preincubated with saturating amounts of the competing antibody for 
25 min in PBS:FCS:AZ. They were then washed and stained under the same conditions 
with biotin-conjugated anti-Thy- 1 (T24/40.7) or biotin-conjugated KJ 16-133 followed 
by avidin coupled with fluorescein or stained directly with FL-KJ1-26. 
Cytofluorimetric Analysis.  The relative fluorescence intensities of individual cells were 
measured using the Cytofluorograf System 50-H (Ortho Diagnostic Instruments,  West- 
wood, MA) equipped with a 5-W argon laser. Forward narrow angle light scatter was used 
as a second parameter to facilitate exclusion of dead and aggregated cells.  Fluorescence 
intensity data is presented as the log of the integrated fluorescence signal. 
The  percentage of antigen-expressing cells  was  determined  using the  Model  2150 
Computer data-processing system. Fluorescence histograms containing equal numbers of 
ceils that were either unstained, stained with either the fluorescein-conjugated secondary 
antibody alone, or stained with both the primary and secondary antibody reagents, were 
constructed and superimposed. Using the data-processing system the control values were 
subtracted from the experimental values on a channel by channel basis. The percentage 
of cells positively stained was determined by integration of the area to the right of the 
point of intersection of the two curves. 
Results 
Production of a Monoclonal Antibody to the Receptor on D0-11.10.  Rat monoclo- 
nal antibodies were screened for binding to the receptor on DO-11.10 by ELISA 
as described in  Materials and  Methods.  Of ~ 1,500 hybridomas screened, about 
9 gave high ELISA readings when added to wells containing DO-11.10 receptor, 
and low readings in wells containing no receptor. These nine hybridomas were 
grown  up in  10-ml  bottles, and their supernatants  screened for their ability to 
precipitate receptor-like proteins from DO-11.10 and from normal T  ceils from 
BALB/c mice, the strain from which the DO-11.10 receptor was derived. Anti- 
Thy-1 precipitations were used as controls. One of these hybridomas, K  J16-133, 
precipitated material running at 85 kd on nonreduced gels from both DO-11.10 
and BALB/c T  cells (Fig.  1). On reducing gels the material from both DO-11.10 
and normal T  cells gave a diffuse band running at ~43 kd (Fig.  1). These results 
suggested that KJ 16-133 precipitated receptors from both DO-11.10 and at least 
a subpopulation of T  cells in normal BALB/c mice. The specificity of KJ 16-133 
was therefore clearly different from that of KJ1-26, the clone-specific antibody 
directed against the Ag/MHC receptor on DO-11.10, since KJ 1-26 did not react 456  ANTIBODY TO  A  T  CELL  RECEPTOR  ALLOTYPE 
FlCtJl~E  1.  lmmunoprecipitation  with  KJ16-133:  normal T  cells compared to  DO-11.10. 
Normal T  cells from BALB/c and SJA lymph node spleen were prepared. These hybridoma 
cells were surface labeled with ~5I. Lysates of the three cell preparations were incubated  with 
Sepharose  beads coupled with rabbit  anti-rat  IgG and preloaded either with rat anti-Thy-I 
monoclonal  antibody  or  with  KJ16-133.  The  immunoprecipitates  were  subjected  to SDS- 
PAGE  under  nonreducing conditions  using  a  10%  acrylamide  gel. The  gel  was  stained, 
destained,  and dried and an autoradiogram was prepared (left and middle  panels).  For the 
KJ 16-133 immunoprecipitates,  the region of the dried gel corresponding to molelcules of 70- 
90,000  tool  wt  was  cut  out,  rehydrated  with  Laemmli  sample  buffer  containing  5%  2- 
mercaptoethanol, and subjected again to SDS-PAGE as before. The gel was stained, destained, 
and dried and an autoradiogram was prepared (right panel). 
with  a  detectable  percentage  of BALB/c T  cells (23,  and  unpublished  data)  nor 
did it precipitate  receptor-like  material  from these  cells (data not shown).  KJ 16- 
133  was cloned,  and  its  clones assayed  for anti-receptor  activity by  ELISA.  All 
clones  tested  were  positive  and  one,  KJ16-133.18  was  chosen  for  further  use. 
This  clone,  the  SNs  of which  were  used  for  all  the  rest  of the  experiments 
described  in this paper will be referred  to as KJ16-133. 
Interestingly,  in the same experiment,  KJ 16-133  failed to precipitate  receptor 
fi'om  SJA  T  cells,  although  these  cells  reacted  normally  with  the  anti-Thy-1 
reagent.  This result  will be explored  in greater detail  below. 
Distribution  of  KJ16-133 Material on Different  T Cell Hybridomas.  The fact that 
KJ16-133  precipitated  a  significant  receptor band  from normal  BALB/c T  cells 
suggested  that  the antibody  was recognizing a  determinant  present  on a  signifi- HASKINS  ET  AL.  457 
cant percentage of T  cell Ag/MHC receptors. KJ 16-133 was therefore screened 
for its ability to precipitate receptor material from a  number of T  cell hybrido- 
mas.  In  each  case,  1~5I surface-labeled  [ysates from the T  cells were incubated 
with Sepharose beads covalently coupled to rabbit anti-rat immunoglobulin and 
then  bound  with  KJ16-133.  Controls (not shown  here)  included precipitations 
front the same cells with  rat anti-mouse  Thy-I.2 antibody, or with  rabbit anti- 
rat intmunoglobulin-coupled beads not coated with a  second antibody. 
After  thorough  washing,  bound  material  was  eluted  using  SDS and  run  on 
nonreducing SDS-PAGE. Some sample gels are shown in Fig. 2. KJ 16-133 bound 
receptors from SKK-45.10 and  D1G10G11  but not from a  number of other T 
cell hybridomas tested, including one of BALB/c origin, 3DT-18.11. 
In some cases hybrids were screened for reactivity with  KJ16-133  by ELISA. 
Some sample data are shown in Table I. The antibody reacted well with five of 
the  hybrids  listed,  including  SKK-9.11  and  3DT-52.5,  but  not  at  all  with  a 
number of other cell lines. 
FIGURE 2.  lmmunoprecipitation with KJ16-133: comparison among a bank ofT cell hybri- 
domas. Eight T cell hybridomas were surface labeled with ~5I. A lysate of each hybridoma 
preparation  was incubated with Sepharose beads coupled with rabbit anti-rat  lgG and pre- 
loaded with KJ16-133. The immunoprecipitates were subjected to SDS-PAGE under nonre- 
ducing conditions using a 7.5% acrylamide slab gel. The gel was stained, destained, and dried 
and an autoradiogram was prepared. 458  ANTIBODY  TO  A  T  CELL  RECEPTOR  ALLOTYPE 
TABLE  l 
Reactivity of KJ16-133 with T Cell Hybridomas and Tumors 
Cell line 
ELISA OD (X  1000) with*: 
Anti-Thy- 1.2  KJ 16-133 
D0-11.10/$4.4  302 -+ 14  146 __. 7 
3DT-52.5  557 --. 34  174 ___ I0 
D1G10GI 1  468 -  9  I01  -+ 8 
SKK-9.11  543 -+  13  79 +  6 
SKK-45.10  637 -+ 22  58 _  3 
3D0-20.10  530 --+ 13  5 +  10 
SKK-2.3  478 +  19  -3  +  4 
SKK-9.19  599 +  10  9  _  5 
AODH-3.4  467 +- 26  -12  +  8 
C6VL-1  388 -+ 14  13 _+  10 
* ELISA  readings  were  calculated  by  averaging  triplicate  wells,  subtracting 
background readings from wells incubated with cells and alkaline phosphatase- 
coupled rabbit anti-rat immunoglobulin but no primary antibody, and combin- 
ing  the  errors  appropriately  to  obtain  standard  errors  for  each  corrected 
reading. 
TABLE  II 
Origins and Reactivities of T Cell Hybridomas and Tumors 
Reaction with 
Cell line  Origin*  Specificities  KJ16-133  Reference 
DO- 11.10  BALB/c  cOVA/I-Ad; I-A~; cOVA/I-A  b  +  9 
3D0-54.8  BALB/c  cOVA/I-Aa; I-A  ~s'k  -  24 
3D0-18.3  BALB/c  cOVA/I-A  d  -  24 
3D0-20.10  BALB/c  cOVA/I-A  a  -  24 
3 DT- 18.11  BALB/c  TGAL/I-A d  -  9 
3 DT-52.5  BA LB/c  D o  +  10 
M DK 16  BALB/c  I-A  k  +  -- 
S 18.4  BALB.k  I-E  d  +  -- 
A2D7DI0  C57BL/6  I-Ed; I-A  b  -  -- 
DIG10G11  C57BL/6  l-Ad; Mls  a'd  +  -- 
SKK-2.3  (SJA ×  C58)F~  KLH/1-A  k  -  -- 
SKK-9.11  (SJA ×  C58)F1  KLH/I-A  k  +  -- 
SKK-45.10  (SJA ×  C58)F1  KLH/I-A~; I-A  b  +  -- 
AODH-3.4  B 10.A  cOVA/I-Ak; I-A  b  -  12 
AODH-7.1  DBA/2  HgG/I-E  d  -  25 
Rb- 17.5  Rb(8.12)5Bnr  KLH/I-A  b  -  26 
5Rb-25.5  Rb(8.12)5Bnr  KLH/I-A  b  -  26 
WeHi7  BALB/c  Unknown  -  -- 
EL-4  C57BL/6  Unknown  -  -- 
C6V L- 1  C57BL/Ka  Unknown  -  1 
BW5147  AKR  Unknown  -  -- 
* Origin of normal T  cell parent donating the receptor of the hybridoma, or of the tumor. 
The  specificities  and  origins  of all  the  T  cell  hybridomas  we  have  tested  so far 
for  reaction  with  KJ 16-133  in  either  of  these  assays  are  shown  in  Table  I I.  The 
normal  T  cell  parents  of  all  the  T  cell  hybridomas  and  tumors  shown  were 
derived  from  strains  of  mice  known  to  express  the  KJ16-133-reactive  determi- HASKINS ET  AL.  459 
nant. Clearly there is no obvious relationship between the specificities or origins 
of those T  cell hybrids with which the antibody reacts. The antibody reacts with 
some but not all closely related hybrids; for example, it binds to DO-11.10, but 
not to 3DO-54.8, a T  cell bybridoma of BALB/c origin that reacts with the same 
cOVA tryptic peptide as DO-11.10 plus I-A  d. The  unpredictable nature of the 
reaction of the antibody is also illustrated  by 3DT-52.5,  which is the only Class 
I-specific T  cell hybrid we have isolated, and yet reacts with KJ 16-133, derived 
from immunization  with the receptor from a Class II-restricted hybrid. Reactiv- 
ity  is  not  limited  to  T  cells specific for antigen  plus  MHC;  some alloreactive 
hybrids also bind the antibody, for example S 18.4. Of potential future interest, 
D 1G 10G 11, a hybrid with reactivity for either I-A  d or Mls  a'd, binds the antibody. 
The Clone-specific Antibody  KJI-26,  and KJ16-133  Precipitated  the Same Mate- 
rial.  We wished to confirm the specificity of KJ16-133 for T  cell receptors by 
demonstrating  that it, and the clone-specific antibody,  KJ 1-26, precipitated  the 
same material from DO-11.10. This was demonstrated by the experiments shown 
in Fig. 3. 
DO-11.10  ~25I-labeled  lysate  was  immunoprecipitated  with  KJ1-26  or  with 
KJ 16-133 or anti-Thy-1.2  absorbed to rabbit anti-rat  immunoglobulin  coupled 
to  Sepharose  4B  beads.  Supernatants  of these  immunoprecipitates  were  then 
divided  in  half,  and  one-half incubated  with  KJ1-26  and  the  other  half with 
KJ16-133.  Bound material from all these reactions was then run on SDS-PAGE 
nonreducing  gels. As shown in  Fig.  3,  KJ1-26 and  KJ16-133 both precipitated 
material running at 85 kd from DO-11.10. Neither KJ1-26 nor KJ16-133 could 
precipitate more material  from the SNs of these incubations.  Both precipitated 
85-kd  material  from  the  supernatants  of anti-Thy-1  incubations.  Thus,  the 
targets of KJ 1-26 and KJ16-133 on DO-11.10 are identical. 
Effects of KJ16-133 on the Response of Target  T Cell Hybridomas.  KJ 1-26,  the 
clone-specific antibody against the receptor for OVA/LA  d on DO-I I. I 0, inhibits 
production  of IL-2  by DO-11.10  in  response  to  OVA/I-A a (2).  In  aggregated 
form,  KJ1-26 stimulates IL-2 production  by DO-11.10 in  the absence of other 
stimuli (22). Similar effects have been seen by us and others working with other 
T  cells and  their  clone-specific antibodies (4-6).  We were not sure that  KJ16- 
133 would have comparable effects. The antibody is not directed at an idiotypic 
portion  of the  receptor,  i.e.,  it  may not  interfere  with  Ag/MHC binding  and 
therefore might not inhibit T  cell responses to this combination. Nevertheless, a 
n umber of hybridomas known to react with KJ 16-133, and a control hybridoma 
known  not  to bind  tbe antibody  (3DO-54.8),  were incubated  with  or without 
their specific targets in the presence or absence of K316-133 antibody, and its 
effects on  their  responses monitored.  Some typical results are  shown in  Table 
III.  KJ16-133  blocked the responses of DO-11.10,  SKK-9.11,  and  D1G10G11 
rather  well.  Interestingly,  in cases in  which the hybridoma tested was known to 
have more than one reactivity, all  were inhibited  by the antibody. Thus,  KJ t 6- 
133  inhibited  the  response  of DO-11.10  to  both  cOVA/I-A  d and  cOVA/1-A  b 
and the response of D 1G 10G 11 to both I-A  d and Mls  ~ although this last inhibition 
was variable and  sometimes  marginal.  The  implications  of this  finding  will  be 
examined in a later paper. The antibody inhibited the response of SKK-45.10 to 
KLH/I-A  k less strongly. SKK-45.10 responds very well to KLH/I-A  k, reacting at 460  ANTIBODY  TO  A  T  CELL  RECEPTOR  ALLOTYPE 
FIGURE  3.  KJ1-26 and KJ16-133 detect the same molecule on DO-11.10. DO-I 1.10 hybri- 
doma cells were surface labeled with ~2~I. Three aliquots of the cell lysate were precleared by 
immunoprecipitation using one of three Sepharose preparations: (a) beads coupled with rabbit 
anti-rat IgG and then preloaded with rat-anti-Thy-1 monoclonal antibody; (b) the same type 
of bead preloaded with KJ16-133; and (c) beads directly coupled with KJI-26. In each case 
the immunoprecipitating  antibody was calculated to be in excess  in relation to the cell lysate. 
The supernatants from each of these first  immunoprecipitations was split into two aliquots 
and a second immunoprecipitation performed with K  J16-I 33 and KJ 1-26 as before. Both the 
first and second immunoprecipitates were subjected to SDS-PAGE under nonreducing condi- 
tions using a  10%  acrylamide slab gel.  The  gel  was  stained, destained, and dried and an 
autoradiogram of the dried gel prepared. 
low concentrations  of KLH  and  with few  Ag-presenting  cells, suggesting that its 
receptors  may  have a  very high  affinity for  KLH/I-A k.  We suspect  that  the  less 
striking effects  of KJ16-133  on  this  hybridoma  may  be  due  to  inability of the HASKINS  ET  AL.  461 
TABLE III 
Effects of K  J16-133 on the Responses to Ag/MHC of Different T Cell 
Hybridomas 
T  cell hybridoma  Stimulus 
U/ml IL-2 produced in the 
presence of: 
No antibody  KJ 16-133" 
DO- 11. I 0  cOVA/I-A  d  320  <  10 
D0-11.10  cOVA/I-A  b  160  <10 
D0-11.10  None  <10  <10 
SKK-9.11  KLH/I-A  k  320  <10 
SKK-9.11  None  <10  <10 
D1GI0GI1  I-A  d  80  <10 
D1G10Gll  Mls  a  160  10 
DIG10GII  None  <10  <10 
SKK-45.10  KLH/1-A  k  640  80 
SKK-45.10  None  <  10  <10 
3DT-52.5  D d  40  320 
3DT-52.5  None  <10  40 
SI 8.4  1-A  d  >700  240 
S18.4  None  <10  80 
3D0-54.8  cOVA/|-A n  640  640 
* 40% culture supernatant of the antibody-secreting hybridoma. 
antibody to compete well  with the reaction of these receptors  with their Ag/ 
MHC targets. 
Perhaps  surprisingly,  this  same  soluble  antibody preparation  of KJ16-133 
stimulated IL-2 production by two T  cell hybridomas with which it could react, 
3DT-52.5 and S 18.4. This effect was not observed with any other of the hybrids 
we tested. It is difficult at this point to account for this result, except to suggest 
that different T  cell hybrids may have different requirements for crosslinking 
their receptors before triggering the cell. As far as 3DT-52.5  is concerned, this 
hybridoma has some unusual properties that may have contributed to the effects 
of KJ16-133.  3DT-52.5 is specific for D  d, a molecule it bears at low (substimu- 
latory)  levels on  its  own  surface.  Interaction  with  its  own  D  d may, however, 
contribute to the stimulation seen when KJ 16-133 is added to the cultures. KJ 16- 
133  had little or no effect on the response to Ag/MHC of 3DO-54.8,  a  T  cell 
hybridoma known not to react with the antibody. 
Taken together, however, we feel that the results shown so far in this paper 
prove that KJ16-133  reacts with the receptors for Ag/MHC on the surfaces of 
some T  cells and not with some other molecule that might be present on some 
but not all hybrids. The nature of the determinant recognized will be discussed 
below. 
KJ16-133-reactive Material on Normal T  Cells.  Antiserum from the donor rat 
for the K  J16 fusion precipitated receptor-like material from normal BALB/c T 462  ANTIBODY  TO  A  T  CELL  RECEPTOR  ALLOTYPE 
cells at the time cells  were taken from the animal and, as shown in Fig.  1, the 
monoclonal antibody KJ16-133  reacted with at least some T  cells  in  BALB/c 
mice. A more extensive survey of different mouse strains was therefore done by 
immunoprecipitation.  The  results  of this  survey,  to  be  described  in  a  later 
publication,  were  that  KJ16-133  reacted  with  at  least  some  T  cells  in  most 
common laboratory strains of mice. 
Further documentation of the finding that SJA-related T  cells  do not react 
with KJ 16-133 is shown in Fig. 4. In this experiment KJ 16-133-reactive material 
was precipitated from BALB/c or SJL T  cells as described above and then run 
in the first dimension on nonreducing SDS-PAGE. The relevant strips were then 
cut out, turned sideways, and run reduced on SDS-PAGE in the second dimen- 
sion. By such procedures BALB/c T  cells  yielded a  band running at 80-85  kd 
nonreduced, and 40-45 kd reduced, as predicted for Ag/MHC receptors (1, 2). 
This band was not apparent on gels from SJL T  cells. 
KJ 16-133  therefore reacts with the receptors on at least some T  cells in most 
strains of mice, but the determinant recognized by the antibody is lacking in SJL 
and SJA animals. Several points concerning this result can be made here. The 
fact that BALB/c T  cells  bear this determinant but SJA T  cells  do not proves 
that the target of KJ16-133 does not map to the Igh  locus, since both BALB/c 
and SJA are Igh 'l.  Furthermore, the fact that SJA and SJL T  cells are negative, 
but  that  B10.S(7R)  T  cells were  found to  bear  the antigen (data not shown), 
suggests it does not map to the MHC. Finally, the fact that SJA and SJL T  cells 
do not bear the antigen allows them to be used as useful negative controls in the 
cytofluorograph experiments described below. 
Distribution  of KJ16-133-reactive  Material  on  T  Cells.  We wished to find out 
wbat percentage of BALB/c T  cells reacted with KJ16-133. Preliminary experi- 
ments were done using conventional binding conditions for the antibody, i.e., 
incubation of T  cells with saturating amounts of KJ16-133 followed by staining 
FIGURE  4.  SJL T  cells do not bind KJI6-133.  SJL and BALB/c T  cells and DO-11.10 were 
•  125  labeled w~th  "I, lysed, and reacted with  KJ 16-133 absorbed to goat anti-rat immuoglobulin- 
coupled  beads.  Bound material  was run on  10%  nonreducing SDS-PAGE.  Strips  containing 
these materials were  then cut out and  run  in  the second dimension on  10%  reducing SDS- 
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with  fluorescein-coupled  mouse  anti-rat  kappa  chain  antibody  (FL-MAR18). 
These conditions gave a population of very faintly stained T  cells. Several other 
protocols were therefore tried, including reaction of the T  cells with KJ16-133 
at  37°C  in  the  presence  of azide.  This  procedure  stained  T  ceils much  more 
strongly. Comparison of 4°C and  37°C staining conditions for DO-11.10 gave 
the same result, i.e., KJ16-133 reacted well with the cells at 37°C and poorly at 
4°C.  Some examples of our results are shown in  Fig.  5.  BALB/c T  cells (96% 
Thy-1 ÷,  data  not  shown)  had  some  autofluorescence  (data  not  shown).  This 
profile was unaffected by incubation with FL-MAR 18 save that a few cells stained 
weakly with FL-MAR18 at both 4°C (not shown) and 37°C (solid line, Fig. 5a). 
Reaction  with  KJ16-133  stained  some  BALB/c  T  cells;  this  was  much  more 
marked  if the  KJ16-133  incubation  was carried  out at  37°C  rather  than  4°C 
(compare  the  dotted and  dashed  lines,  Fig.  5a).  There  was no staining  above 
background of SJL T  cells (97% Thy-1 ÷, data not shown) under any conditions 
(Fig.  5b shows data with  37°C  incubated cells). Integration  of the areas under 
the curves shown in Fig. 5a, and subtraction of controls showed that  KJ16-133 
reacted with 19.5% of BALB/c T  cells at 37 °C and a similar percentage, though 
less strongly, at 4 ° C. Preliminary results suggested that this percentage of staining 
T  cells is the same in other strains of mice that react with the antibody. 
As mentioned above, the antibody showed the same temperature sensitivity in 
its reaction  with  the  T  cell  hybridoma  DO-11.10.  100%  of these cells stained 
weakly with KJ16-133 at 4°C and strongly at 37°C (Fig. 5c). By contrast staining 
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FIGURE  5.  KJ16-133 stains only a portion of peripheral T  cells in BALB/c mice. BALB/c or 
SJL  T  cells or  DO-I 1.10  were stained with fluoroscein-coupled monoclonal mouse anti-rat 
kappa chain (FL-MAR  18).  In some cases these cells had been preincubated at 4°C or 37°C 
in azide with saturating amounts of KJ 16-133. Cells were then thoroughly washed and analyzed 
for fluorescence staining using a cytofluorograph. 464  ANTIBODY  TO  A  T  CELL  RECEPTOR  ALLOTYPE 
with the clone-specific antibody,  KJ1-26, was relatively unaffected by the incu- 
bation temperature (Fig. 5 d). 
These results showed that the determinant recognized by KJl6-133 is present 
on ~20% of peripheral T  cells in reactive mouse strains, and that it is apparently 
more readily exposed at physiological temperatures than in the cold. 
KJ16-133  Does  Not  Bind  to  the  Same  Determinants  as  a  Clone-spec~c  Anti- 
body.  We wished to find out what portion of the T  cell receptor was recognized 
by KJ16-133.  The fact that  the antibody does not react with all  T  cells proves 
that  it does not recognize a determinant  common to all receptors.  We felt that 
three targets could therefore be suggested. KJ 16-133 might bind a determinant 
on a  family of V-regions,  it might  bind to one of several J  regions, or it might 
bind to one of several constant regions that  might  be expressed by one of the 
chains of the T  cell receptor.  For example, Yanagi et al. and Hedrick et al. (27, 
28) have recently described a  cDNA clone that  probably codes for one of the 
chains of the T  cell receptor. It has been shown that these probes detect a family 
of genes including an unknown number of V regions, more than one expressed 
J  region,  and  two  closely related  but  not  identical  constant  regions  (28,  29). 
Thus, any of the possibilities suggested above as targets for KJ16-133 would be 
supported by what is known from molecular biological studies. 
First we tried to find out whether KJ 16-133 would bind to one of the separated 
chains of the T  cell receptor.  After the chain  had been reduced and separated 
by either  NEPHGE  in  9  M  urea  or  incubation  at  room  ternp  with  1%  SDS, 
neither  KJ16-133  nor  KJ1-26,  the  clone-specific  antibody  reacted  with  the 
receptor from  DO-11.10  (data  not shown).  Since these methods  involve harsh 
denaturation  procedures,  we decided to try a  different approach  in  which  the 
chains were reacted with the antibodies whilst they were still more or less native. 
The  receptor  was  therefore  isolated  from  125I-surface  labeled  DO-11.10  by 
binding  to  KJ1-26  beads,  elution  with  diethylamine,  and  rapid  neutralization. 
Half of this sample was then  reduced with  0.03  M  dithiothreitol  and alkylated 
with excess iodoacetamide. We then tested the ability of KJ16-133 and the clone- 
specific antibody, KJ 1-26, to reprecipitate the receptor. The precipitated material 
was analyzed for its content of ~ and ~ chains by NEPHGE. 
The results of this experiment are shown in Table IV. KJ1-26 and KJ16-133 
were able to reprecipitate an equal quantity of unreduced receptor. Not surpris- 
ingly, the precipitated material contained both ~- and/3-chains (in DO-11.10 the 
c~-chain  is  usually somewhat  more  heavily labeled  with  1251 than  the  ~-chain). 
Reduction  and  alkylation  did  not affect the  ability of KJ16-133  to precipitate 
both the c~- and B-chains of the receptor; however, precipitation  by KJI-26 was 
dramatically lowered by this procedure. 
From this experiment we concluded that KJ1-26 and KJ16-133 were recogniz- 
ing different  determinants  on  the receptor.  We could not tell  whether  or not 
KJ16-133  would  recognize  isolated,  native  a-  or  fl-chains,  since  both  were 
precipitated  by  the  antibody,  probably  because  the  alkylation  and  reduction 
procedure under native conditions did not separate them. 
A second type of experiment was used to show that KJ 1-26 and KJ 16-133 bind 
different parts of the receptor molecule. DO-11.10 cells were preincubated with 
saturating concentrations of anti-Thy-l or KJ1-26 at 4°C, or KJ16-133 at 37°C HASKINS  ET  AL. 
TABLE IV 
Sensitivity of Determinants on the Receptor to Reduction and Alkylation 
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Treatment of the receptor of 
D0-11.10 purified with KJ1-26 
antibody 
Reduction 
and alkyla-  Reprecipitated 
with  tion 
Total 
lmmunoprecipitated  cpm* 
recovered in: 
a-Chain  ~-Chain 
-  KJ1-26  1,500  510  357 
+  KJ1-26  300  70  70 
-  KJ16-133  1,650  587  325 
+  KJ16-133  1,700  490  490 
Receptor was immunoprecipitated from lysate of ~25I-labeled  DO- 11.10 cells using 
KJ1-26 antibody  coupled  to Sepharose  beads.  The bead-bound  receptor was 
eluted with 0.05 M diethylamine (DEA). neutralized, aliquoted, and lyophilized. 
Four aliquots containing 9,000 cpm each were resuspended in 0.5 ml of 0.05 M 
DEA containing 0.5% NP-40. Two samples were made 30 mM in DTT. After 
15 rain at room temperature all samples were made 50 mM in IAA. Reduced 
and alkylated samples were neutralized with 0.05 M DEA. Nonreduced samples 
were neutralized with CO2. Each sample received 1.5 ml of standard lysis buffer 
containing PBS, 1% NP-40, 50 rnM IAA, and 10  -4 M PMSF and was subjected 
to immunoprecipitation  with either  K  J1-26-  or KJ16-133-coupled Sepharose 
beads. The bound receptor was then again eluted with 0.05 M DEA and subjected 
to NEPHGE analysis to separate a- and 0-chains. Shown are the cpm eluted from 
the second immunoprecipitation and the cpm recovered in the a- and B-contain- 
ing fractions of the NEPHGE gels. 
in  PBS:FCS:AZ.  The cells were then  washed and  incubated with  FL-KJ1-26 or 
biotin-conjugated anti-Thy- 1 (4 ° C) or biotin-conjugated  KJ 16-133  followed by 
fluorescein-conjugated  avidin,  again  in  PBS:FCS:AZ.  The  Cytofluorograf was 
then used to assess bow well the antibodies competed witb each other for binding 
to  DO-1 1.10.  The  averaged  results  of three  experiments are  shown  in  Fig.  6. 
Preincubation  with each antibody very successfully blocked subsequent binding 
of the  same  antibody.  Preincubation  with  anti-Thy-1  had  little  effect  on  the 
subsequent binding of KJ 1-26 or KJ 16-133.  Likewise, KJ 1-26 and KJ 16-133  did 
not block binding of anti-Thy-1.  Significantly,  KJ16-133 did not block binding 
of KJI-26,  and  KJ1-26  preincubation  only  inhibited  by  50%  the  subsequent 
binding  of KJ16-133.  The  50%  inhibition  of KJ16-133  binding  by  KJ16-133 
preincubation,  in the absence of significant inhibition  when  the experiment was 
done the other way around,  could have occurred for several reasons. The most 
likely explanation  is that K  J1-26 was able to inhibit sterically the binding of the 
bulky  complex  of  biotinylated  KJ16-133  and  fluoroscein-conjugated  avidin, 
whereas KJ 16-133  was not able to hinder the binding of the smaller FL-KJ 1-26. 
However,  since  no  inhibition  was  seen  ill  one  combination,  and  only  partial 
inhibition  in  the other,  we concluded  that  KJ1-26 and  KJ16-133  were probably 
binding to different regions of the receptor molecule. 
Since KJ 1-26 is known to bind to the idiotypic, antigen plus MHC binding site 
on  the  receptor  (2,  23),  we  concluded  from  these  experiments  that  KJ16-133 
was probably binding to a  different region, for example the constant region. 466  ANTIBODY  TO  A  T  CELL  RECEPTOR  ALLOTYPE 
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FIGURE 6.  KJ 16-I 33 and KJ 1-26 bind different sites on the receptor. DO-11.10 cells were 
preincubated in PBS:FCS:AZ with saturating concentrations ofanti-Thy-1 or KJ1-26 or KJ16- 
133 at 37 °C. The cells were then washed and stained with  FL-KJ1-26  or biotin-conjugated 
KJ 16-133 or biotin-conjugated anti-Thy-1 at the appropriate temperatures. Cells stained with 
biotin-conjugated antibodies were reacted after washing  with avidin coupled to fluorescein. 
Relative mean fluorescence was determined for the cells stained under each set of conditions 
using a Cytofluorograf System  50H and compared with controls incubated with no stain or 
with fluoroscein-conjugated avidin alone. These two controls were identical. In the absence of 
blocking antibodies, 100% of the cells stained with each reagent. For each set of conditions 
the percent inhibition of immunofluorescent staining was calculated by the following formula: 
(mean  fluorescence with  blocking antibody minus  background control) divided by (mean 
fluorescence without blocking antibody minus background control). The figure depicts the % 
inhibition of fluorescence -+ standard error of the mean of three identical experiments. 
Discussion 
This paper describes the production  and properties of a  monoclonal antibody 
that recognizes the Ag/MHC  receptor of some but not all murine T  cells. It was 
produced  in  a  rat  immunized  with  isolated  receptor  from  a  cloned  T  cell 
hybridoma, DO-11.10, bound to its antiidiotypic antibody, KJ 1-26, and S.  aureus. 
Cross-reactive  antisera  were  raised  relatively easily in  this  rat;  only about  five 
immunizations were required. Interestingly, of the  1,500 hybridomas we assayed 
from this animal, none were secreting cIonotypic antibodies, the type most usually 
raised when  whole cell immunizations are used. This may be due to masking of 
clonotypic determinants  on  DO-11.1 O's receptor by KJ 1-26. 
The  monoclonal  antibody  we  obtained,  KJ16-133,  had  several  unexpected 
properties.  First,  it  reacted  with  only  a  subpopulation  of  T  cells  from,  for 
example, BALB/c  mice.  In repeated  experiments  the percentage  of cells recog- 
nized was  ~15-20%.  This  was apparent  not  only from  staining data,  shown  in HASKINS ET  AL.  467 
this paper, but also from the results of immunoprecipitation experiments. Order- 
of-magnitude calculations about  J25I-labeling of Ag/MHC receptors on T  cells, 
assuming between 20,000 and  40,000  receptors/cell,  had  led us to expect that 
KJ16-133  would precipitate  between 2 and  10  times more radioactivity  in  the 
receptor band from  BALB/c T  cells than  it did were it to react with receptors 
on all T  cells. The restricted reactivity of KJ 16-133 was also, of course, manifest 
by its reactions with different T  cell hybridomas and tumors. The antibody only 
reacted  with  ~25%  of  all  T  cell  hybridomas  we  have  tested.  Even  T  cell 
hybridomas with closely related origins and specificities were not similarly reac- 
tive. DO-11.10 and 3DO-54.8, for example, were both derived from BALB/c T 
cells primed with cOVA, they recognized the same cOVA tryptic peptide plus I- 
A ~ (24), and yet the receptor of one of these hybrids reacted with KJ 16-133, and 
the  receptor of the  other did not.  In  fact,  even a  cursory glance at  the  list of 
hybrids  with  which  KJ16-133  does or  does  not  react  reveals  that  there  is  no 
obvious pattern  to the determinant  recognized by the antibody.  It is present on 
both I-A and I-E restricted T  cells. It is found on T  cells that respond to Ag plus 
self-I, and on T  cells specific for allogeneic I-A or I-E. It is present on the only 
Class  I-reactive  T  cell hybridoma  we have,  3DT-52.5.  Thus,  the determinant 
recognized here does not define a particular  Ag or I specificity, indeed, it does 
not even distinguish between Class I- and Class II-reactive receptors. (In support 
of this conclusion, preliminary experiments have suggested that the determinant 
is  present  on  both  L3T4-  and  Lyt  2-bearing  normal  T  cells.)  In  addition, 
experiments to be published shortly suggest that  the determinant  is present on 
subpopulations of cortisone-sensitive thymocytes, indicating that it is not a marker 
solely for late, fully mature T  cells. 
We have done a number of experiments to examine the relationship between 
the determinant  recognized  by KJ16-133, and  that  bound by the antiidiotypic 
antibody,  KJ1-26.  The  clone-specificity and ability of the  latter  to define both 
antigen  and  MHC-reactivity  (6,  23)  both  suggest  that  this  antibody  detects 
determinants  in or close to the V, D, or J  regions of the receptors (27-29).  We 
found that K  J16-133 probably binds to some part of the molecule that does not 
involve these regions because KJ1-26 and  KJ16-133 block each other's binding 
to the receptor only marginally or not at all, because the determinant recognized 
by KJ 1-26 is sensitive to reduction and alkylation unlike the target of KJ 16-133, 
and because the binding of one antibody is temperature sensitive and the other 
not.  Taken together,  these data suggest that the most likely target of KJ 16-133 
binding is a  determinant  on one of the constant regions of the T  cell receptor 
polypeptides. Gascoigne et al. (29), for example, have described two similar but 
not identical constant regions for one of the chains of the T  cell receptor, both 
expressed on peripheral T cells. It is possible that KJ 16-133 distinguishes between 
these.  It  should  be pointed  out,  however,  that  if a  constant  region  isotype is 
being defined by KJ16-133,  this is not related  to the specificity or function  of 
the T  cell itself since both Class II-reactive, helper T  cell hybridomas (2, 9) and 
a Class I-reactive, cytotoxic T  cell hybridoma (10) bear the determinant. 
It is difficult to account for the temperature sensitivity of the binding of KJ 16- 
133 to cells, since so little is known about the way in which the receptor operates, 
and how it is exposed at different temperatures.  All biochemical and molecular 468  ANTIBODY  TO  A  T  CELL  RECEPTOR  ALLOTYPE 
biological data point to the idea that at least one of the chains of the receptor is 
a transmembrane protein (1-6, 27, 28), since the molecule appears to be released 
fi'om T  cells bearing it only by detergent solubilization.  Unpublished data from 
our  laboratory  have also shown  that  it  may be stripped  from  cell  surfaces by 
proteolysis.  In  man  (30,  31),  and  perhaps  in  mouse  (Dr. J.  Allison,  personal 
communication),  it is also known that the receptor is closely associated with the 
complex of T3  proteins.  Our  current  hypothesis is  that  a  determinant  on  the 
receptor  that  lies  close to  the  membrane  or  the  T3  complex  might  be  more 
readily or often exposed at  37°C  because of increased  membrane  fluidity and 
that this accounts for the effects of temperature on KJ 16-133 reactivity. 
There is some question why the idiotypic determinant  bound by KJ 16-26 is so 
sensitive to reduction and alkylation, whereas that detected by KJ16-133 is not. 
Immunoglobulin  molecules  do  not  dissociate  when  reduced  and  alkylated  at 
neutral  pH, and  VH and  Vc domains even remain  associated in  Fv fragments, 
suggesting  that  noncovalent,  probably hydrophobic,  forces hold  the  chains  or 
fragments together (32). Whether or not reduced or alkylated immunoglobulins 
continue to react with antiidiotypic reagents depends on the individual antibody 
(Dr.  M.  Gefter,  personal  communication).  T  ceil  receptors  seem  to  be  like 
immunoglobulins  in  that  reduction  and alkylation  under  nondenaturing  condi- 
tions  does  not  separate  the  two  chains  of the  heterodimer,  as  shown  by the 
continued  precipitation  of both  chains  by  KJ16-133  with  efficiency equal  to 
precipitation  of the  nonreduced  molecule.  Lack  of reactivity of this  complex 
with KJ1-26 suggests that reduction does cause a change in configuration of the 
variable regions of the receptor. 
A  final  point  of  interest  about  KJ16-133  is  the  strain  distribution  of  its 
reactivity. The antibody reacts with BALB/c T  cells (Igh~), and with T  cells from 
most  other  strains  tested,  including  several  congenic  with  BALB/c  at  H-2 
(BALB.K and BALB.B) and also BI0.S(7R).  It does not bind, however, T  cells 
from SJL or SJA (Igh")  mice. These findings suggest that  the genes controlling 
this  determinant  do not  map  to  Igh,  or to the  MHC itself.  A  more  extensive 
strain survey and mapping study will be published shortly. 
Summary 
We have prepared  a  monoclonal  antibody,  KJ16-133,  from the cells of a  rat 
immunized  with the purified receptor for antigen  plus I-A of a  BALB/c T  cell 
hybridoma,  DO-11.10.  Unlike  most other monoclonal  anti-receptor  antibodies 
that  have been described before, KJ16-133  is not clone specific.  It reacts with 
-20%  of the  receptors on T  cells of normal  BALB/c mice.  It also reacts with 
about the same percentage of antigen-specific, major histocompatibility complex 
(MHC)-restricted or allogeneic I-region specific T  cell hybridomas.  Reaction of 
KJ 16-133 with a given T  cell hybridoma does not seem to depend on the antigen 
specificity or MHC-restricting element of the T  cell in question. 
The determinant recognized by KJ 16-133 has some unexpected properties. It 
is absent in several strains of mice including SjL/j and SJA/20, but present on 
the T  cells of most other commonly used strains.  The determinant  recognized 
therefore  does not  map  to Igh.  Our  experiments  suggest  that  a  clone-specific 
"antiidiotypic" antibody and KJ 16-133 recognize determinants on different parts HASKINS ET AL.  469 
of the receptor. For example, the binding of a  clone-specific antibody to target 
T  cells is relatively temperature insensitive, whereas KJ 16-133 binds well to cells 
at  37°C  but  poorly to  cells at  4°C.  The  determinant  recognized by a  clone- 
specific antibody is sensitive to reduction and alkylation of the receptor, whereas 
KJ 16-133 reactivity is not. Finally, binding of KJ 16-133 at saturating concentra- 
tions to target T  cells does not block the  binding of a  clone-specific antibody. 
Similarly,  binding  of a  clone-specific antibody only marginally inhibits binding 
of KJ16-133. 
Taken  together,  these  results  suggest  that  KJ16-133  is  directed  against  an 
allelic determinant on T  cells that may be close to the membrane, and not in the 
receptor binding  site  for antigen  plus  MHC.  The antibody  may recognize an 
allele of a constant region isotype, or an allele of a J  region. 
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Cambier and David DiGiusto for their help with cytofluorograph analysis.  We would also 
like to  thank  Ella  Kushnir, James  Leibson, and  Michelle Pigeon  very much  for their 
excellent technical assistance and Edna Squillante for typing the manuscript. 
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